Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency

Kuniaki Saito, Suwako Fujigaki, Melvyn P. Heyes, Katsumi Shibata, Masao Takemura, Hidehiko Fujii, Hisayasu Wada, Akio Noma, Mitsuru Seishima

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Marked increases in metabolites of the L-tryptophan-kynurenine pathway, L-kynurenine and quinolinic acid (Quin), were observed in serum and cerebrospinal fluid (CSF) of both the rat and human with renal insufficiency. The mechanisms responsible for their accumulation after renal insufficiency were investigated. In patients with chronic renal insufficiency, elevated levels of serum L-kynurenine and Quin were reduced by hemodialysis. In renal-insufficient rats, Quin and L-kynurenine levels in serum, brain, and CSF were also increased parallel to the severity of renal insufficiency. Urinary excretion of Quin (3.5-fold) and L-kynurenine (2.8-fold) was also increased. Liver L-tryptophan 2,3-dioxygenase activity (TDO), a rate-limiting enzyme of the kynurenine pathway, was increased in proportion to blood urea nitrogen and creatinine levels. Kynurenine 3-hydroxylase and quinolinic acid phosphoribosyltransferase were unchanged, but the activities of kynureninase, 3-hydroxyanthranilate dioxygenase, and aminocarboxymuconate-semialdehyde decarboxylase (ACMSDase) were significantly decreased. Systemic administrations of pyrazinamide (ACMSDase inhibitor) increased serum Quin concentrations in control rats, demonstrating that changes in body ACMSDase activities in response to renal insufficiency are important factors for the determination of serum Quin concentrations. We hypothesize the following ideas: that increased serum L-kynurenine concentrations are mainly due to the increased TDO and decreased kynureninase activities in the liver and increased serum Quin concentrations are due to the decreased ACMSDase activities in the body after renal insufficiency. The accumulation of CSF L-kynurenine is caused by the entry of increased serum L-kynurenine, and the accumulation of CSF Quin is secondary to Quin from plasma and/or Quin precursor into the brain.

Original languageEnglish
JournalAmerican Journal of Physiology - Renal Physiology
Volume279
Issue number3 48-3
Publication statusPublished - 05-10-2000
Externally publishedYes

Fingerprint

Quinolinic Acid
Kynurenine
Renal Insufficiency
kynureninase
Serum
Cerebrospinal Fluid
Dioxygenases
Tryptophan
Kynurenine 3-Monooxygenase
Tryptophan Oxygenase
Pyrazinamide
Liver
Blood Urea Nitrogen
Brain
Chronic Renal Insufficiency
Renal Dialysis
Creatinine

All Science Journal Classification (ASJC) codes

  • Physiology
  • Urology

Cite this

Saito, K., Fujigaki, S., Heyes, M. P., Shibata, K., Takemura, M., Fujii, H., ... Seishima, M. (2000). Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency. American Journal of Physiology - Renal Physiology, 279(3 48-3).
Saito, Kuniaki ; Fujigaki, Suwako ; Heyes, Melvyn P. ; Shibata, Katsumi ; Takemura, Masao ; Fujii, Hidehiko ; Wada, Hisayasu ; Noma, Akio ; Seishima, Mitsuru. / Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency. In: American Journal of Physiology - Renal Physiology. 2000 ; Vol. 279, No. 3 48-3.
@article{0f45303d1a4e4794bd4242621fcd0911,
title = "Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency",
abstract = "Marked increases in metabolites of the L-tryptophan-kynurenine pathway, L-kynurenine and quinolinic acid (Quin), were observed in serum and cerebrospinal fluid (CSF) of both the rat and human with renal insufficiency. The mechanisms responsible for their accumulation after renal insufficiency were investigated. In patients with chronic renal insufficiency, elevated levels of serum L-kynurenine and Quin were reduced by hemodialysis. In renal-insufficient rats, Quin and L-kynurenine levels in serum, brain, and CSF were also increased parallel to the severity of renal insufficiency. Urinary excretion of Quin (3.5-fold) and L-kynurenine (2.8-fold) was also increased. Liver L-tryptophan 2,3-dioxygenase activity (TDO), a rate-limiting enzyme of the kynurenine pathway, was increased in proportion to blood urea nitrogen and creatinine levels. Kynurenine 3-hydroxylase and quinolinic acid phosphoribosyltransferase were unchanged, but the activities of kynureninase, 3-hydroxyanthranilate dioxygenase, and aminocarboxymuconate-semialdehyde decarboxylase (ACMSDase) were significantly decreased. Systemic administrations of pyrazinamide (ACMSDase inhibitor) increased serum Quin concentrations in control rats, demonstrating that changes in body ACMSDase activities in response to renal insufficiency are important factors for the determination of serum Quin concentrations. We hypothesize the following ideas: that increased serum L-kynurenine concentrations are mainly due to the increased TDO and decreased kynureninase activities in the liver and increased serum Quin concentrations are due to the decreased ACMSDase activities in the body after renal insufficiency. The accumulation of CSF L-kynurenine is caused by the entry of increased serum L-kynurenine, and the accumulation of CSF Quin is secondary to Quin from plasma and/or Quin precursor into the brain.",
author = "Kuniaki Saito and Suwako Fujigaki and Heyes, {Melvyn P.} and Katsumi Shibata and Masao Takemura and Hidehiko Fujii and Hisayasu Wada and Akio Noma and Mitsuru Seishima",
year = "2000",
month = "10",
day = "5",
language = "English",
volume = "279",
journal = "American Journal of Physiology - Renal Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "3 48-3",

}

Saito, K, Fujigaki, S, Heyes, MP, Shibata, K, Takemura, M, Fujii, H, Wada, H, Noma, A & Seishima, M 2000, 'Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency', American Journal of Physiology - Renal Physiology, vol. 279, no. 3 48-3.

Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency. / Saito, Kuniaki; Fujigaki, Suwako; Heyes, Melvyn P.; Shibata, Katsumi; Takemura, Masao; Fujii, Hidehiko; Wada, Hisayasu; Noma, Akio; Seishima, Mitsuru.

In: American Journal of Physiology - Renal Physiology, Vol. 279, No. 3 48-3, 05.10.2000.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency

AU - Saito, Kuniaki

AU - Fujigaki, Suwako

AU - Heyes, Melvyn P.

AU - Shibata, Katsumi

AU - Takemura, Masao

AU - Fujii, Hidehiko

AU - Wada, Hisayasu

AU - Noma, Akio

AU - Seishima, Mitsuru

PY - 2000/10/5

Y1 - 2000/10/5

N2 - Marked increases in metabolites of the L-tryptophan-kynurenine pathway, L-kynurenine and quinolinic acid (Quin), were observed in serum and cerebrospinal fluid (CSF) of both the rat and human with renal insufficiency. The mechanisms responsible for their accumulation after renal insufficiency were investigated. In patients with chronic renal insufficiency, elevated levels of serum L-kynurenine and Quin were reduced by hemodialysis. In renal-insufficient rats, Quin and L-kynurenine levels in serum, brain, and CSF were also increased parallel to the severity of renal insufficiency. Urinary excretion of Quin (3.5-fold) and L-kynurenine (2.8-fold) was also increased. Liver L-tryptophan 2,3-dioxygenase activity (TDO), a rate-limiting enzyme of the kynurenine pathway, was increased in proportion to blood urea nitrogen and creatinine levels. Kynurenine 3-hydroxylase and quinolinic acid phosphoribosyltransferase were unchanged, but the activities of kynureninase, 3-hydroxyanthranilate dioxygenase, and aminocarboxymuconate-semialdehyde decarboxylase (ACMSDase) were significantly decreased. Systemic administrations of pyrazinamide (ACMSDase inhibitor) increased serum Quin concentrations in control rats, demonstrating that changes in body ACMSDase activities in response to renal insufficiency are important factors for the determination of serum Quin concentrations. We hypothesize the following ideas: that increased serum L-kynurenine concentrations are mainly due to the increased TDO and decreased kynureninase activities in the liver and increased serum Quin concentrations are due to the decreased ACMSDase activities in the body after renal insufficiency. The accumulation of CSF L-kynurenine is caused by the entry of increased serum L-kynurenine, and the accumulation of CSF Quin is secondary to Quin from plasma and/or Quin precursor into the brain.

AB - Marked increases in metabolites of the L-tryptophan-kynurenine pathway, L-kynurenine and quinolinic acid (Quin), were observed in serum and cerebrospinal fluid (CSF) of both the rat and human with renal insufficiency. The mechanisms responsible for their accumulation after renal insufficiency were investigated. In patients with chronic renal insufficiency, elevated levels of serum L-kynurenine and Quin were reduced by hemodialysis. In renal-insufficient rats, Quin and L-kynurenine levels in serum, brain, and CSF were also increased parallel to the severity of renal insufficiency. Urinary excretion of Quin (3.5-fold) and L-kynurenine (2.8-fold) was also increased. Liver L-tryptophan 2,3-dioxygenase activity (TDO), a rate-limiting enzyme of the kynurenine pathway, was increased in proportion to blood urea nitrogen and creatinine levels. Kynurenine 3-hydroxylase and quinolinic acid phosphoribosyltransferase were unchanged, but the activities of kynureninase, 3-hydroxyanthranilate dioxygenase, and aminocarboxymuconate-semialdehyde decarboxylase (ACMSDase) were significantly decreased. Systemic administrations of pyrazinamide (ACMSDase inhibitor) increased serum Quin concentrations in control rats, demonstrating that changes in body ACMSDase activities in response to renal insufficiency are important factors for the determination of serum Quin concentrations. We hypothesize the following ideas: that increased serum L-kynurenine concentrations are mainly due to the increased TDO and decreased kynureninase activities in the liver and increased serum Quin concentrations are due to the decreased ACMSDase activities in the body after renal insufficiency. The accumulation of CSF L-kynurenine is caused by the entry of increased serum L-kynurenine, and the accumulation of CSF Quin is secondary to Quin from plasma and/or Quin precursor into the brain.

UR - http://www.scopus.com/inward/record.url?scp=0033826593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033826593&partnerID=8YFLogxK

M3 - Article

C2 - 10966936

AN - SCOPUS:0033826593

VL - 279

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 1931-857X

IS - 3 48-3

ER -